The advancement opens the possibility of producing a brand-new generation of antimicrobial bone-implantable gadgets with enhanced tissue-implant combination.
“This exciting development, coupled with our coating’s ability to irreversibly attach bone-signalling biomolecules, allows us to create biomedical implant surfaces that simultaneously repel infection and integrate with native body tissues,” states ProfessorMarcela Bilek, SydneyNano, CharlesPerkins Centre, and Faculty of Science.
“This new class of antimicrobial interfaces will benefit patients suffering from bone fracture, osteoporosis, and bone cancer.” states Dr Behnam Akvavan
“The next phase of the research study is to coat patient-specific permeable 3D structures produced by 3D printing of titanium by our partners at UMC Utrecht, where subsequent implant in-vivo screening will be carried out.
“We hope to conduct clinical trials by attracting industry support and funding. This is an incredibly exciting project with the potential for real impact. Our partnership with UMC Utrecht demonstrates the power of multi-disciplinary collaboration across borders to tackle seemingly intractable problems,” concluded Dr Akhavan.
The brand-new research study was released in the Journal of Materials Chemistry B.
Source: University of Sydney